Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, drug pipeline outlook, the ...
GlobalData on MSN4d
Sanofi’s $17bn sale of Opella to US investors advances following government dealA stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...
Head of Investor Relations Welcome to the Q3 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide number 3. Here we have the usual ...
Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to ...
PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...
A health-care buyout has been sealed by an American firm against a rival Gallic offer. That’s despite the asset being a ...
French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...
AFP on MSN4d
Sanofi pursues sale of France's leading painkiller to US investment fund after controversyFrench pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...
The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than ...
Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...
Sanofi attributed its double-digit growth to growth in vaccines, particularly its latest flu jab. Another major revenue ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback